Research

An update on anti-NMDA receptor encephalitis for neurologists and psychiatrists: mechanisms and models February 27, 2021

https://pubmed.ncbi.nlm.nih.gov/31326280/

Learn more
Long-term outcomes in temporal lobe epilepsy with glutamate decarboxylase antibodies February 27, 2021

https://pubmed.ncbi.nlm.nih.gov/32221776/

Learn more
Diagnosis and significance of antibody titres in anti-NMDA receptor encephalitis, a retrospective study February 27, 2021

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4006368/

Learn more
Neurologic syndromes related to anti-GAD65, Clinical and serologic response to treatment February 27, 2021

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7136051/

Learn more
Glycine receptor autoantibodies disrupt inhibitory neurotransmission February 27, 2021

https://academic.oup.com/brain/article/142/11/3398/5583666

Learn more
DPPX potassium channel antibody: frequency, clinical accompaniments, and outcomes in 20 patients. February 27, 2021

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4240433/

Learn more
Oro-Bucco-Lingual Dyskinesia, Weight Loss, and Cognitive Decline in Anti-DPPX Antibody-Mediated Encephalitis February 27, 2021

https://onlinelibrary.wiley.com/doi/10.1002/mdc3.13058

Learn more
Antibodies to the GABA(B) receptor in limbic encephalitis with seizures: case series and characterisation of the antigen February 27, 2021

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2824142/

Learn more
Clinical Characteristics of Anti-GABA-B Receptor Encephalitis February 27, 2021

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7253677/

Learn more
Encephalitis With Antibodies Against the GABAB Receptor: High Mortality and Risk Factors February 27, 2021

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6798040/

Learn more